China’s Breakthrough in Yttrium-90 Production
China has announced a significant achievement in the field of nuclear medicine: the successful mastery of commercial reactor production of Yttrium-90 (Y-90) glass microspheres. This breakthrough was accomplished at the Qinshan Nuclear Power Plant’s “He Fu-1” reactor, where the Y-90 irradiated glass microspheres were successfully discharged and passed all relevant inspections.
This development is a major milestone for China, as it signifies the nation’s capability for batch production of Y-90. Yttrium-90 glass microspheres are a crucial component in selective internal radiation therapy (SIRT), a highly effective treatment for certain types of liver cancer. Previously, the production of medical isotopes like Y-90 often relied on specialized facilities or imports.
The ability to produce Y-90 domestically and at scale will likely have a profound impact on cancer treatment in China, potentially increasing accessibility to this advanced therapy for a greater number of patients. https://www.facebook.com/jeff.mah.5/posts/pfbid02VX2A4aQ55FMmXTVYxTjkrhw4SKLt2E3W5WfwKSz2ixsV53wTWQ8yQKHpWbfxJU7Dl?__cft__[0]=AZVtAcZ-Ot8VOlKmKreVMKHO1YjPT-CDwDlVT6czrij5kK0F-xTWTB6W0zeNGHTaXJvxkYj-vb6VMmQp44ID1oGKD4HboftC5yjgXuWywm_0XnZQlN8Haew_xdkbx2u3tLW2U0qHLtqtOxZbTlC_8I7YEUeCFb3eool-SHCc4e0W2w&__tn__=%2CO%2CP-R
